Back

Consistent excess mortality risk after heart failure onset in patients with atrial fibrillation, survival trends over 30 years of follow up, a nationwide registry-based study

26 August 2023 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Heart failure: determinants of outcome Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Elias Choha

Sahlgrenska Academy - University of Gothenburg, Gothenburg (Sweden)

7 More presentations in this session

Presentation thumbnail
Impact of hypochloremia on mortality in heart failure patients: systematic review and metanalysis.
Doctor K. Stankowski (Milan, IT)
Abstract Slides Video
Presentation thumbnail
The prognostic impact of cardio-renal anaemia syndrome in Japanese acute decompensated heart failure patients stratified by left ventricular ejection fraction
Mr T. Moriki (Kochi, JP)
Abstract Slides Video
Presentation thumbnail
The association between left ventricular ejection fraction and long-term survival: a large hospital-based cohort study in taiwan
Doctor H. Chang (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Efficacy of intravenous iron therapy in iron-deficient patients with heart failure: an updated systematic review and meta-analysis
Mr M. Freitas (Imperatriz, BR)
Abstract Slides Video
Presentation thumbnail
Impact of eGFR slope upon mortality in a real world heart failure cohort
Doctor M. Vanderheyden (Aalst, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure: determinants of outcome

The Event

Event poster

ESC Congress 2023

26 August 2023 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Influence of persistent atrial fibrillation on the prognosis of heart failure with preserved, mildly reduced, and reduced ejection fraction in women and men.
thumbnail
Congress Presentation
Temporal trends in clinical outcomes in heart failure patients with and without atrial fibrillation: a nationwide study from 1997-2018
thumbnail
Congress Presentation
The impact of timing and order of disease development on the risk of mortality in atrial fibrillation and heart failure patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources